These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 15771919)

  • 21. [Pravastatin, a new cholesterol synthesis inhibitor for lowering increased serum cholesterol].
    Hoppichler F; Lechleitner M; Patsch JR
    Z Gesamte Inn Med; 1992 Nov; 47(11):523-7. PubMed ID: 1462678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial.
    Nakamura H; Arakawa K; Itakura H; Kitabatake A; Goto Y; Toyota T; Nakaya N; Nishimoto S; Muranaka M; Yamamoto A; Mizuno K; Ohashi Y;
    Lancet; 2006 Sep; 368(9542):1155-63. PubMed ID: 17011942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Risk factors in elderly patients selected by primary care physicians for hypolipemic treatment].
    Barretto AC; Wajngarten M; Gebara OC; do Serro Azul JB; Pierri H; Nussbacher A; Pivotto L; Bellotti G; Pileggi F
    Arq Bras Cardiol; 1996 Aug; 67(2):93-8. PubMed ID: 9110440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes of plasma inflammatory markers after withdrawal of statin therapy in patients with hyperlipidemia.
    Li JJ; Li YS; Chu JM; Zhang CY; Wang Y; Huang Y; Chen J; Yuan JQ; Huang YL
    Clin Chim Acta; 2006 Apr; 366(1-2):269-73. PubMed ID: 16343471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of probucol on elderly hypercholesterolemic patients in the FAST study.
    Sawayama Y; Maeda S; Ohnishi H; Okada K; Hayashi J
    Fukuoka Igaku Zasshi; 2006 Jan; 97(1):15-24. PubMed ID: 16613215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved outcome after acute coronary syndromes with an intensive versus standard lipid-lowering regimen: results from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) trial.
    Rouleau J
    Am J Med; 2005 Dec; 118 Suppl 12A():28-35. PubMed ID: 16356805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pravastatin for cardiovascular event primary prevention in patients with mild-to-moderate hypertension in the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Study.
    Kushiro T; Mizuno K; Nakaya N; Ohashi Y; Tajima N; Teramoto T; Uchiyama S; Nakamura H;
    Hypertension; 2009 Feb; 53(2):135-41. PubMed ID: 19104004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of pravastatin for primary prevention of coronary artery disease in Japan.
    Nagata-Kobayashi S; Shimbo T; Matsui K; Fukui T
    Int J Cardiol; 2005 Sep; 104(2):213-23. PubMed ID: 16168816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Both hepatitis C virus and Chlamydia pneumoniae infection are related to the progression of carotid atherosclerosis in patients undergoing lipid lowering therapy.
    Sawayama Y; Okada K; Maeda S; Ohnishi H; Furusyo N; Hayashi J
    Fukuoka Igaku Zasshi; 2006 Aug; 97(8):245-55. PubMed ID: 17087362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
    Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X
    Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.
    Shepherd J; Cobbe SM; Ford I; Isles CG; Lorimer AR; MacFarlane PW; McKillop JH; Packard CJ
    N Engl J Med; 1995 Nov; 333(20):1301-7. PubMed ID: 7566020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phytosterols dissolved in diacylglycerol oil reinforce the cholesterol-lowering effect of low-dose pravastatin treatment.
    Takeshita M; Katsuragi Y; Kusuhara M; Higashi K; Miyajima E; Mizuno K; Mori K; Obata T; Ohmori R; Ohsuzu F; Onodera Y; Sano J; Sawada S; Tabata S; Tokimitsu I; Tomonobu K; Yamashita T; Yasukawa T; Yonemura A; Nakamura H
    Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):483-91. PubMed ID: 17964767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of the National Cholesterol Education Program and joint European treatment criteria and clinical benefit in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).
    Gotto AM; Whitney E; Stein EA; Shapiro DR; Clearfield M; Weis S; Jou JY; Langendörfer A; Beere PA; Watson DJ; Downs JR; de Cani JS
    Eur Heart J; 2000 Oct; 21(19):1627-33. PubMed ID: 10988016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pravastatin: efficacy and safety in elderly patients with primary hypercholesterolemia. Open multicenter study].
    Giannini SD; Diament J
    Arq Bras Cardiol; 1993 Aug; 61(2):131-7. PubMed ID: 8297223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular endothelial growth factor serum concentrations in hypercholesterolemic patients.
    Trapé J; Morales C; Molina R; Filella X; Marcos JM; Salinas R; Franquesa J
    Scand J Clin Lab Invest; 2006; 66(3):261-7. PubMed ID: 16714254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pravastatin--ocular side effects after a two year follow-up?
    Behrens-Baumann W; Thiery J; Fieseler HG; Seidel D
    Lens Eye Toxic Res; 1990; 7(3-4):311-8. PubMed ID: 2129219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholesterol-lowering drugs. Some drugs with demonstrated efficacy but different benefits in primary and secondary prevention.
    Prescrire Int; 1999 Aug; 8(42):116-20. PubMed ID: 11503831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Consistency of lipid-altering effects of ezetimibe/simvastatin across gender, race, age, baseline low density lipoprotein cholesterol levels, and coronary heart disease status: results of a pooled retrospective analysis.
    Ose L; Shah A; Davies MJ; Rotonda J; Maccubbin D; Tribble D; Veltri E; Mitchel Y
    Curr Med Res Opin; 2006 May; 22(5):823-35. PubMed ID: 16709304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired myocardial vasodilatation during hyperaemic stress is improved by simvastatin but not by pravastatin in patients with hypercholesterolaemia.
    Yokoyama I; Inoue Y; Moritan T; Ohtomo K; Nagai R
    Eur Heart J; 2004 Apr; 25(8):671-9. PubMed ID: 15084372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Achieving lipid goals in real life: the Dutch DISCOVERY study.
    Bots AF; Kastelein JJ;
    Int J Clin Pract; 2005 Dec; 59(12):1387-94. PubMed ID: 16351669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.